This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Brainstorm Cell Therapeutics Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Haggai Kaspi: Innovator in Neurodegenerative Disease Treatment
Introduction
Haggai Kaspi is a notable inventor based in Ganei Tikva, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic methods for neurodegenerative diseases. His innovative work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Haggai Kaspi holds a patent for "MSC-NTF specific exosomes and use thereof." This patent encompasses highly-characterized isolated exosomes, methods for their production, and their application in treating diseases, especially neurodegenerative disorders. His work in this area highlights the importance of exosomes in medical treatments and showcases his commitment to advancing healthcare solutions.
Career Highlights
Haggai Kaspi is associated with Brainstorm Cell Therapeutics Ltd., a company dedicated to developing innovative therapies for neurodegenerative diseases. His role in this organization has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Haggai has worked alongside talented colleagues such as Jonathan Semo and Yael Gothelf. Their combined expertise fosters a collaborative environment that enhances the potential for innovative breakthroughs in their research.
Conclusion
Haggai Kaspi's contributions to the field of biotechnology, particularly through his patent on exosomes, demonstrate his dedication to improving treatments for neurodegenerative diseases. His work at Brainstorm Cell Therapeutics Ltd. and collaborations with esteemed colleagues further solidify his position as a key innovator in this vital area of research.